Skip to main content

Table 2 Medical resource utilization and prescribed medications in 2008 (France)

From: Prescribed therapy for asthma: therapeutic ratios and outcomes

  R = 0% 0% < R < 50% R ≥ 50% p-value
All patients     
Number of patients 1,176 1,358 2,053  
Age, years (mean) 28.1 28.4 29.5 <0.0001
Gender, female (%) 54.7% 53.5% 55% 0.66
Number of GP visits (mean) 5.3 6.5 5.6 <0.0001
Prescribed therapy (a)     
Number of respiratory medication units (mean) 5.1 18.6 8.7 <0.0001
Patients with ≥ 1 prescription of LABA-ICS fixed combination (%) - 71.2% 81.2% <0.0001
Number of short-acting beta agonists units (mean) 2.9 6 1.8 <0.0001
Systemic corticosteroids     
Patients with ≥ 1 prescription (%) 21.9% 36.1% 30.5% <0.0001
Number of units (mean) 0.6 1.2 0.8 <0.0001
Antibiotics (b)     
Patients with ≥ 1 prescription (%) 46.5% 55.7% 53% <0.0001
Number of units (mean) 1.3 2.1 1.7 <0.0001
Patients with at least 6 prescriptions of respiratory medications in 2008
Number of patients 367 1,153 1,152  
Systemic corticosteroids     
Patients with ≥ 1 prescription (%) 21% 36% 32.1% <0.0001
Number of units (mean) 0.7 1.2 1 0.05
Antibiotics (b)     
Patients with ≥ 1 prescription (%) 43.9% 55.3% 52% 0.0006
Number of units (mean) 1.3 2 1.8 <0.0001
  1. (a)Canisters for inhaled therapy and packages for oral therapy in France.
  2. (b)Beta-lactams, cephalosporins (first to third generation), macrolides and fluoroquinolones.